BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 12655917)

  • 1. Venlafaxine-induced delirium.
    Howe C; Ravasia S
    Can J Psychiatry; 2003 Mar; 48(2):129. PubMed ID: 12655917
    [No Abstract]   [Full Text] [Related]  

  • 2. Venlafaxine-induced hair loss.
    Pitchot W; Ansseau M
    Am J Psychiatry; 2001 Jul; 158(7):1159-60. PubMed ID: 11431245
    [No Abstract]   [Full Text] [Related]  

  • 3. Venlafaxine withdrawal reactions.
    Louie AK; Lannon RA; Kirsch MA; Lewis TB
    Am J Psychiatry; 1996 Dec; 153(12):1652. PubMed ID: 8942467
    [No Abstract]   [Full Text] [Related]  

  • 4. Venlafaxine-induced hyponatremia.
    Gupta AK; Saravay SM
    J Clin Psychopharmacol; 1997 Jun; 17(3):223-5. PubMed ID: 9169969
    [No Abstract]   [Full Text] [Related]  

  • 5. Benztropine in the treatment of venlafaxine-induced sweating.
    Garber A; Gregory RJ
    J Clin Psychiatry; 1997 Apr; 58(4):176-7. PubMed ID: 9164433
    [No Abstract]   [Full Text] [Related]  

  • 6. Suspected complication of treatment with venlafaxine.
    Wilson R; Jenkins P
    J Clin Psychopharmacol; 1997 Aug; 17(4):323. PubMed ID: 9241015
    [No Abstract]   [Full Text] [Related]  

  • 7. Serotonin syndrome due to association of venlafaxine, maprotiline and reboxetine.
    Bertolín-Guillén JM; Climent-Díaz B; Navarré-Gimeno A
    Eur Psychiatry; 2004 Nov; 19(7):456-7. PubMed ID: 15504661
    [No Abstract]   [Full Text] [Related]  

  • 8. Venlafaxine-associated hypomania in unipolar depression.
    Chand PK; Kalyani GS; Murthy P
    Can J Psychiatry; 2004 Jul; 49(7):496. PubMed ID: 15362257
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of venlafaxine discontinuation symptoms with ondansetron.
    Raby WN
    J Clin Psychiatry; 1998 Nov; 59(11):621-2. PubMed ID: 9862610
    [No Abstract]   [Full Text] [Related]  

  • 10. Withdrawal syndrome after discontinuation of venlafaxine.
    Agelink MW; Zitzelsberger A; Klieser E
    Am J Psychiatry; 1997 Oct; 154(10):1473-4. PubMed ID: 9326838
    [No Abstract]   [Full Text] [Related]  

  • 11. Serotonin syndrome induced by administration of venlafaxine and phenelzine.
    Heisler MA; Guidry JR; Arnecke B
    Ann Pharmacother; 1996 Jan; 30(1):84. PubMed ID: 8773172
    [No Abstract]   [Full Text] [Related]  

  • 12. Possible venlafaxine withdrawal syndrome.
    Farah A; Lauer TE
    Am J Psychiatry; 1996 Apr; 153(4):576. PubMed ID: 8599410
    [No Abstract]   [Full Text] [Related]  

  • 13. [Delirium during withdrawal of venlafaxine].
    van Noorden MS; Vergouwen AC; Koerselman GF
    Ned Tijdschr Geneeskd; 2002 Jun; 146(26):1236-7. PubMed ID: 12132141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced testosterone level in a venlafaxine treated patient.
    Bell S; Shipman M
    Ann Clin Psychiatry; 2000 Sep; 12(3):171-3. PubMed ID: 10984008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast pain associated with venlafaxine.
    Bhatia SC; Gupta S; Theesen KA
    J Clin Psychiatry; 1996 Sep; 57(9):423. PubMed ID: 9746453
    [No Abstract]   [Full Text] [Related]  

  • 16. Severe hypertriglyceridemia secondary to venlafaxine and fluoxetine.
    Teitelbaum M
    Psychosomatics; 2001; 42(5):440-1. PubMed ID: 11739916
    [No Abstract]   [Full Text] [Related]  

  • 17. Venlafaxine withdrawal syndrome.
    Macbeth R; Rajagopalan M
    Aust N Z J Med; 1998 Apr; 28(2):218. PubMed ID: 9612536
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute adverse cutaneous reaction after the concomitant use of venlafaxine and orphenadrine citrate plus paracetamol in a depressed patient.
    Papadimitriou GN; Theleritis CG; Papageorgiou CC; Kalogeromitros D; Syrigou E; Gregoriou S; Rabavilas AD
    J Eur Acad Dermatol Venereol; 2006 Sep; 20(8):1019. PubMed ID: 16922966
    [No Abstract]   [Full Text] [Related]  

  • 19. Onset of confusion in the context of late-life depression.
    Mulsant BH
    J Psychiatry Neurosci; 2007 Mar; 32(2):152. PubMed ID: 17353943
    [No Abstract]   [Full Text] [Related]  

  • 20. Topiramate in venlafaxine-induced visual hallucinations in an obese patient with a posterior cerebral artery infarction.
    Anghelescu I; Klawe C; Himmerich H; Szegedi A
    J Clin Psychopharmacol; 2001 Aug; 21(4):462-4. PubMed ID: 11476137
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.